Page last updated: 2024-10-18

dihydroxyphenylalanine and Atrophy, Muscular, Peroneal

dihydroxyphenylalanine has been researched along with Atrophy, Muscular, Peroneal in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dupuis, JM1
Brucher, JM1
Tranchant, C1
Ruh, D1
Warter, JM1

Reviews

1 review available for dihydroxyphenylalanine and Atrophy, Muscular, Peroneal

ArticleYear
[Type II Charcot-Marie-Tooth and dopa-sensitive Parkinson disease].
    Revue neurologique, 1994, Volume: 150, Issue:1

    Topics: Charcot-Marie-Tooth Disease; Dihydroxyphenylalanine; Humans; Male; Middle Aged; Parkinson Disease, S

1994

Other Studies

1 other study available for dihydroxyphenylalanine and Atrophy, Muscular, Peroneal

ArticleYear
[Charcot-Marie-Tooth disease type II and dopa-sensitive Parkinson syndrome].
    Revue neurologique, 1994, Volume: 150, Issue:10

    Topics: Aged; Charcot-Marie-Tooth Disease; Dihydroxyphenylalanine; Humans; Male; Parkinson Disease

1994